ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Connecticut » Gastroenterology

Top Gastroenterology Prescribers in Connecticut

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HECTOR PUN MD

Gastroenterology

18,398

$1.19M

834
730 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 40%

$65
Average prescription price

Avg: $146

PRAKASH HUDED MD

Gastroenterology

17,719

$1.05M

425
374 are 65+

13%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 40%

$59
Average prescription price

Avg: $146

HOUSEIN WAZAZ M.D.

Gastroenterology

4,042

$745K

542
357 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 40%

$184
Average prescription price

Avg: $146

PAMELA CONNORS M.D.

Gastroenterology

3,923

$340K

538
480 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 40%

$87
Average prescription price

Avg: $146

KIRK ZACHARY M.D.

Gastroenterology

3,496

$135K

224
204 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 40%

$39
Average prescription price

Avg: $146

HEATHER NISBETH M.D.

Gastroenterology

3,470

$261K

302
280 are 65+

7%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 40%

$75
Average prescription price

Avg: $146

KAREN DUFOUR M.D.

Gastroenterology

2,914

$253K

344
319 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 40%

$87
Average prescription price

Avg: $146

GERALD FRANKLIN MD

Gastroenterology

2,618

$220K

213
185 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 40%

$84
Average prescription price

Avg: $146

ROBERT PLANSKY MD

Gastroenterology

2,483

$232K

174
157 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 40%

$94
Average prescription price

Avg: $146

JEFFREY BREITER M.D.

Gastroenterology

2,392

$571K

473
402 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 40%

$239
Average prescription price

Avg: $146

ALBERT MARANO MD

Gastroenterology

2,184

$357K

441
362 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 40%

$163
Average prescription price

Avg: $146

DAVID SACK M.D.

Gastroenterology

2,118

$308K

274
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 40%

$145
Average prescription price

Avg: $146

AJIT KOKKAT M.D.

Gastroenterology

2,000

$409K

462
287 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

60%
prescriptions for brand name drugs

Avg: 40%

$205
Average prescription price

Avg: $146

RALPH GIARNELLA M.D.

Gastroenterology

1,883

$222K

115
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 40%

$118
Average prescription price

Avg: $146

ROGELIO PEREZ MD

Gastroenterology

1,782

$293K

255
191 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 40%

$164
Average prescription price

Avg: $146

NEIL KLEIN M.D.

Gastroenterology

1,672

$86.1K

145
132 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

10%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 40%

$52
Average prescription price

Avg: $146

KOFI ATTA-MENSAH M.D.

Gastroenterology

1,636

$108K

174
144 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 40%

$66
Average prescription price

Avg: $146

BHUPINDER LYALL M.D.

Gastroenterology

1,626

$266K

352
263 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 40%

$164
Average prescription price

Avg: $146

ROBERT SCHWARTZ M.D.

Gastroenterology

1,604

$242K

234
202 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

50%
prescriptions for brand name drugs

Avg: 40%

$151
Average prescription price

Avg: $146

JOEL GARSTEN M.D

Gastroenterology

1,568

$238K

339
285 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

34%
prescriptions for brand name drugs

Avg: 40%

$152
Average prescription price

Avg: $146

PAUL SHAPIRO MD

Gastroenterology

1,557

$197K

314
275 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 40%

$127
Average prescription price

Avg: $146

JANET DICKINSON MD

Gastroenterology

1,550

$147K

143
119 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

9%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

28%
prescriptions for brand name drugs

Avg: 40%

$95
Average prescription price

Avg: $146

EDWARD TOFFOLON M.D.

Gastroenterology

1,522

$233K

267
218 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 40%

$153
Average prescription price

Avg: $146

ALI HEMACHA MD

Gastroenterology

1,469

$276K

326
254 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

44%
prescriptions for brand name drugs

Avg: 40%

$188
Average prescription price

Avg: $146

THOMAS FELDMAN MD

Gastroenterology

1,441

$273K

191
134 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 40%

$189
Average prescription price

Avg: $146

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank